Deanna van Gestel: Celebrating Rachna Shroff’s Legacy in Oncology
Robin Zon, Steve Tulk, Aparna Parikh, Deanna van Gestel and Rachna Shroff

Deanna van Gestel: Celebrating Rachna Shroff’s Legacy in Oncology

Deanna van Gestel, the CEO of Women Leaders in Oncology and a member of Conquer Cancer’s Board of Directors, shared on LinkedIn:

”Some people spend their careers lifting others up. Rachna Shroff is one of them.

Rachna Shroff has dedicated her life to advancing cancer care, particularly in biliary cancers, and to the young scientists coming up behind her. She has been deeply committed to ASCO and to Conquer Cancer, the ASCO Foundation, all while navigating a health journey of her own with the same grace and strength she brings to everything she does.

Now a groundswell of support is building around a dream close to Dr. Shroff’s heart: an endowed Conquer Cancer – Rachna Shroff Young Investigator Award in Biliary Cancer. It will help launch the next generation of oncology researchers for years to come, just as an early award once launched Dr. Shroff’s own remarkable career.

The goal is $1.35 million to endow the award in perpetuity, and there’s a heartfelt wish to see it realized now. Every gift, of any size, brings it closer.

Two ways to help: give, or, just as important, share this with your network.

Dr. Shroff tells her story in her own words. I hope you’ll read it, and stand with her.”

Aparna Parikh, Program Director for the GI Medical Oncology Program at Mass General Brigham, shared Deanna van Gestel‘s post, adding:

”Bumping for one the most remarkable women I know. Rachna Shroff is a tour de force. Brilliant, generous, gracious, and fun she has been such an inspiration to me over the last decade and fortunate to call her a dear friend and so lucky to have her in my orbit and feel lucky to be a part of hers (hers is a big one that loves her deeply!)

Deeply invested in making this dream of hers happen.”

Robin Zon, Chair of ASCO Association 2026-2027, Past President of Michiana Hematology Oncology, Current Director of Breast Oncology, Cincinnati Cancer Advisors, shared Aparna Parikh‘s post, adding:

Please donate and support this incredible opportunity – which Dr Rachna Schroff is leading. An endowed YIA for research in biliary cancer would guarantee the development of pipeline of physician- scientists working on this rare cancer.

What a way to honor Dr Shroff and amplify her dedication to caring for all patients, especially those with cholangiocarcinoma.”

Steve Tulk, Chief Technology Officer of the Vaniam Group, shared on LinkedIn:

”Dr. Rachna Shroff built her career in pancreatic and biliary cancers, and she took on biliary back when there was almost nothing to offer the people who had it. She ran the trials. She trained the researchers who will keep running them. She helped change what a diagnosis in this disease means.

She is now facing a serious health journey of her own, and she writes about it in her own words at the link.

What she is asking for is not for herself. She wants to permanently endow a Young Investigator Award in Biliary Cancer, so that a young researcher in this disease is funded every year from here forward. It takes $1.35 million. A Young Investigator Award is what launched her own career, so she knows exactly what it buys.

And she has said she wants to see it finished now, while she can be there to celebrate it with the people who built this field alongside her.

That is not a small thing to ask for, and it is not a small thing to give.

Give if you can. If you cannot, put this in front of someone who can. Both count.”

Deanna van Gestel: Celebrating Rachna Shroff’s Legacy in Oncology

Other articles featuring Rachna Shroff on OncoDaily.